Grant: Team Grant: Human Immunology Initiative: Standardization Core - LOI
University of British Columbia
$25,000.00
Canadian Autoimmunity Standardization Core (CAN-ASC)
FY 2017-18
Summary
A functional immune system is essential for health. In a process called immune tolerance, it fends off dangerous foreign substances but leaves the body's own tissues untouched. Failure of immune tolerance causes chronic autoimmune diseases in which the immune system sees the body's own cells as foreign and attacks them. The chronic diseases caused by a lack of immune tolerance lower the quality of life of 2 million Canadians with autoimmune disease and place a high demand on our health care system and economy.
Although immune tolerance is intrinsic to health, translating what we have learned from animal models about how this process works, and how it can be manipulated to improve human health has been a major challenge. Studying immunity in humans is difficult due to inter-individual variation, inability to readily sample tissues affected by autoimmunity, and the need to work across multiple sites. There is a pressing need for research strategies that work within the constraints of humans.
To address this challenge, we propose a new network which is dedicated to developing and disseminating protocols required to study human autoimmunity. The Canadian Autoimmunity Standardization Core (CAN-ASC) will develop consensus-driven protocols and make the resulting standard operating procedures available through web-based platforms and country-wide training opportunities. CAN-ASC Team members bring together world-class expertise in the most common autoimmune diseases affecting Canadians of all ages and sexes: type 1 diabetes, inflammatory bowel disease, rheumatological diseases, multiple sclerosis, and autoimmune skin disorders. We also bring a track record of working collaboratively in multi-disciplinary teams, and in addressing ethical issues. By creating and disseminating consensus-driven approaches to measure human autoimmunity, CAN-ASC will create a resource which enables rigorous and comprehensive approaches to study autoimmunity in humans.
Department
Program
Team Grant: Human Immunology Initiative: Standardization Core - LOI
Recipient
Location
British Columbia, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
367544
Name
Levings Megan K
Region
British Columbia
Country
Canada
Orgtype
Research Institution; Institution Paid
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Human Immunology - Standardization Core
Projecttitle
Canadian Autoimmunity Standardization Core (CAN-ASC)
Programtype2
Operating Grants
Orgnameinp2
University of British Columbia
Cihramount2
$25,000
Cihrequipment2
$0
Programname2
Team Grant: Human Immunology Initiative: Standardization Core - LOI
Keyworddelim
Autoimmunity; Clinical Immunology; Flow Cytometry; Genomics; Human Immunology; Metabolomics; Microbiome; Proteomics
Abstract
A functional immune system is essential for health. In a process called immune tolerance, it fends off dangerous foreign substances but leaves the body's own tissues untouched. Failure of immune tolerance causes chronic autoimmune diseases in which the immune system sees the body's own cells as foreign and attacks them. The chronic diseases caused by a lack of immune tolerance lower the quality of life of 2 million Canadians with autoimmune disease and place a high demand on our health care system and economy.
Although immune tolerance is intrinsic to health, translating what we have learned from animal models about how this process works, and how it can be manipulated to improve human health has been a major challenge. Studying immunity in humans is difficult due to inter-individual variation, inability to readily sample tissues affected by autoimmunity, and the need to work across multiple sites. There is a pressing need for research strategies that work within the constraints of humans.
To address this challenge, we propose a new network which is dedicated to developing and disseminating protocols required to study human autoimmunity. The Canadian Autoimmunity Standardization Core (CAN-ASC) will develop consensus-driven protocols and make the resulting standard operating procedures available through web-based platforms and country-wide training opportunities. CAN-ASC Team members bring together world-class expertise in the most common autoimmune diseases affecting Canadians of all ages and sexes: type 1 diabetes, inflammatory bowel disease, rheumatological diseases, multiple sclerosis, and autoimmune skin disorders. We also bring a track record of working collaboratively in multi-disciplinary teams, and in addressing ethical issues. By creating and disseminating consensus-driven approaches to measure human autoimmunity, CAN-ASC will create a resource which enables rigorous and comprehensive approaches to study autoimmunity in humans.
Competitiondate
201706
Approvedterm2
0 yr 6 mths
Pinamesdelim
Levings, Megan K
Approvedterm
0 an 6 mois
Cihrcontribution2
~ $25,000~ $0~